Allogene Therapeutics Reports First Quarter 2025 Financial Results and Business Update

Go back to Allogene Therapeutics Reports First Quarter 2025 Financial Results and Business Update
(NASDAQ: ALLO) Delayed: 1.77 +0.01 (0.57%)
Previous Close $1.76    52 Week High
Open $1.80    52 Week Low
Day High $1.80    P/E N/A 
Day Low $1.75    EPS
Volume 1,790,398